Phosphorylation of Schizosaccharomyces pombe Dss1 mediates direct binding to the ubiquitin‐ligase Dma1 in vitro
Protein Science · 2023
DOI: 10.1002/pro.4733 ↗At a glance
Journal article in Protein Science, 2023. Written by Nina L Jacobsen and 8 co-authors. Institution: Structural Biology and NMR Laboratory, University of Copenhagen, Copenhagen N, Denmark. Major MEDLINE topics: Cell Cycle Proteins, Schizosaccharomyces, Schizosaccharomyces pombe Proteins, Ubiquitin-Protein Ligases. Cited 1 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Novo Nordisk Fonden, Villum Fonden.
Abstract (original language)
Intrinsically disordered proteins (IDPs) are often multifunctional and frequently posttranslationally modified. Deleted in split hand/split foot 1 (Dss1—Sem1 in budding yeast) is a highly multifunctional IDP associated with a range of protein complexes. However, it remains unknown if the different functions relate to different modified states. In this work, we show that Schizosaccharomyces pombe Dss1 is a substrate for casein kinase 2 in vitro, and we identify three phosphorylated threonines in its linker region separating two known disordered ubiquitin‐binding motifs. Phosphorylations of the threonines had no effect on ubiquitin‐binding but caused a slight destabilization of the C‐terminal α‐helix and mediated a direct interaction with the forkhead‐associated (FHA) domain of the RING‐FHA E3‐ubiquitin ligase defective in mitosis 1 (Dma1). The phosphorylation sites are not conserved and are absent in human Dss1. Sequence analyses revealed that the Txx(E/D) motif, which is important for phosphorylation and Dma1 binding, is not linked to certain branches of the evolutionary tree. Instead, we find that the motif appears randomly, supporting the mechanism of ex nihilo evolution of novel motifs. In support of this, other threonine‐based motifs, although frequent, are nonconserved in the linker, pointing to additional functions connected to this region. We suggest that Dss1 acts as an adaptor protein that docks to Dma1 via the phosphorylated FHA‐binding motifs, while the C‐terminal α‐helix is free to bind mitotic septins, thereby stabilizing the complex. The presence of Txx(D/E) motifs in the disordered regions of certain septin subunits may be of further relevance to the formation and stabilization of these complexes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Structural Biology and NMR Laboratory, University of Copenhagen, Copenhagen N, Denmark.
- REPIN, University of Copenhagen, Copenhagen N, Denmark.
- The Linderstrøm Lang Centre for Protein Science, Department of Biology, University of Copenhagen, Copenhagen N, Denmark.
- Department of Computer Science, University of Copenhagen, Copenhagen Ø, Denmark.
ORCID profiles: Nina L Jacobsen, Magnus Bloch, Peter S Millard, Sarah F Ruidiaz, Jonas D Elsborg, Wouter Boomsma, Ruth Hendus-Altenburger, Rasmus Hartmann-Petersen, Birthe B Kragelund
Funding
- Novo Nordisk Fonden
- Villum Fonden
Cite
APA
Jacobsen, N. L., Bloch, M., Millard, P. S., Ruidiaz, S. F., Elsborg, J. D., Boomsma, W., Hendus-Altenburger, R., Hartmann-Petersen, R., & Kragelund, B. B. (2023). Phosphorylation of Schizosaccharomyces pombe Dss1 mediates direct binding to the ubiquitin‐ligase Dma1 in vitro. Protein Science. https://doi.org/10.1002/pro.4733
Vancouver
Jacobsen NL, Bloch M, Millard PS, Ruidiaz SF, Elsborg JD, Boomsma W, et al. Phosphorylation of Schizosaccharomyces pombe Dss1 mediates direct binding to the ubiquitin‐ligase Dma1 in vitro. Protein Science. 2023. doi:10.1002/pro.4733
BibTeX
@article{Jacobsen2023,
author = {Jacobsen, Nina L and Bloch, Magnus and Millard, Peter S and Ruidiaz, Sarah F and Elsborg, Jonas D and Boomsma, Wouter and Hendus-Altenburger, Ruth and Hartmann-Petersen, Rasmus and Kragelund, Birthe B},
title = {Phosphorylation of Schizosaccharomyces pombe Dss1 mediates direct binding to the ubiquitin‐ligase Dma1 in vitro},
journal = {Protein Science},
year = {2023},
doi = {10.1002/pro.4733}
}
EUVIMED